Sign in
Back
The use of corticosteroid therapy in refractory Kawasaki patients
Journal article   Peer reviewed

The use of corticosteroid therapy in refractory Kawasaki patients

Sulaiman M Al-Mayouf
Clinical rheumatology, Vol.23(1), pp.11-13
02/2004
DOI: https://doi.org/10.1007/s10067-003-0752-z
PMID: 14749974

Abstract

Child Child, Preschool Drug Resistance Female Glucocorticoids - administration & dosage Glucocorticoids - therapeutic use Humans Immunoglobulins, Intravenous - therapeutic use Infant Injections, Intravenous Male Methylprednisolone - administration & dosage Methylprednisolone - therapeutic use Mucocutaneous Lymph Node Syndrome - drug therapy Mucocutaneous Lymph Node Syndrome - pathology Retrospective Studies Treatment Outcome
We retrospectively reviewed four children with Kawasaki disease refractory to the standard therapy. Although three patients had unusual complications, all four responded to intravenous methylprednisolone. This therapy may be considered early in the treatment of selected cases of Kawasaki disease.

Metrics

1 Record Views

Details